BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28336186)

  • 1. Variation in head and neck cancer care in the Netherlands: A retrospective cohort evaluation of incidence, treatment and outcome.
    de Ridder M; Balm AJM; Baatenburg de Jong RJ; Terhaard CHJ; Takes RP; Slingerland M; Dik E; Sedee RJE; de Visscher JGAM; Bouman H; Willems SM; Wouters MW; Smeele LE; van Dijk BAC;
    Eur J Surg Oncol; 2017 Aug; 43(8):1494-1502. PubMed ID: 28336186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-specific incidence and treatment patterns of head and neck cancer in the Netherlands-A cohort study.
    Halmos GB; Bras L; Siesling S; van der Laan BFAM; Langendijk JA; van Dijk BAC
    Clin Otolaryngol; 2018 Feb; 43(1):317-324. PubMed ID: 28950049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers.
    Trama A; Licitra L; Cavalieri S; Bonfarnuzzo S; Baili P; Ciarfella A; Parente P; Almadori G; Ansarin M; Bacigalupo A; Baumeister P; Baujat B; Bossi P; Cavalera E; Cercato MC; Dieleman F; Fakhry N; Ferraresi V; Gaino F; Galizia D; Halamkova J; Halme E; Hardillo J; Hofauer B; Kinloch E; Livi L; Locati LD; Mattheis S; Mercante G; Mirabile A; Molteni G; Orlandi E; Persio R; Sciallero S; Smeele L; Tagliabue M; Valentini V; Van Harpen C; Westphalen CB; Botta L
    PLoS One; 2023; 18(3):e0283071. PubMed ID: 36928072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head and neck cancer: an analysis of the incidence, patterns of treatment, and survival at the University of Iowa.
    Hussey DH; Latourette HB; Panje WR
    Ann Otol Rhinol Laryngol Suppl; 1991 Apr; 152():2-16. PubMed ID: 2018299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site.
    Simard EP; Torre LA; Jemal A
    Oral Oncol; 2014 May; 50(5):387-403. PubMed ID: 24530208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in treatment and outcome of patients with rectal cancer by region, hospital type and volume in the Netherlands.
    Elferink MA; Krijnen P; Wouters MW; Lemmens VE; Jansen-Landheer ML; van de Velde CJ; Langendijk JA; Marijnen CA; Siesling S; Tollenaar RA
    Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S74-82. PubMed ID: 20598844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database.
    Guntinas-Lichius O; Wendt T; Buentzel J; Esser D; Lochner P; Mueller A; Schultze-Mosgau S; Altendorf-Hofmann A
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):55-63. PubMed ID: 19568769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based assessment of relationship between volume of practice and outcomes in head and neck cancer patients treated in a provincially coordinated radiotherapy program.
    McLay M; Stedford A; Yurkowski E; Matlock S; Cheung W; Tran E; Berthelet E; Wu J; Olson R
    Radiother Oncol; 2017 Jul; 124(1):174-181. PubMed ID: 28625605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in epidemiology and treatment and outcome for head and neck cancer: a population-based long-term analysis from 1996 to 2011 of the Thuringian cancer registry.
    Guntinas-Lichius O; Wendt TG; Kornetzky N; Buentzel J; Esser D; Böger D; Müller A; Schultze-Mosgau S; Schlattmann P; Schmalenberg H
    Oral Oncol; 2014 Dec; 50(12):1157-64. PubMed ID: 25459063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database.
    Carvalho AL; Nishimoto IN; Califano JA; Kowalski LP
    Int J Cancer; 2005 May; 114(5):806-16. PubMed ID: 15609302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.
    Tiwana MS; Hay J; Wu J; Wong F; Cheung W; Olson RA
    Laryngoscope; 2014 Oct; 124(10):2287-91. PubMed ID: 24729185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival.
    van Harten MC; Hoebers FJ; Kross KW; van Werkhoven ED; van den Brekel MW; van Dijk BA
    Oral Oncol; 2015 Mar; 51(3):272-8. PubMed ID: 25541458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands.
    van Dijk BA; Brands MT; Geurts SM; Merkx MA; Roodenburg JL
    Int J Cancer; 2016 Aug; 139(3):574-83. PubMed ID: 27038013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of adenoid cystic carcinoma in nova scotia: 30-year population-based epidemiologic study.
    Bonaparte JP; Hart R; Trites J; Taylor MS
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):642-8. PubMed ID: 19128670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epidemiological evaluation of salivary gland cancer in the Netherlands (1989-2010).
    de Ridder M; Balm AJ; Smeele LE; Wouters MW; van Dijk BA
    Cancer Epidemiol; 2015 Feb; 39(1):14-20. PubMed ID: 25454260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of head and neck squamous cell carcinoma in The Netherlands during the era of HPV-related oropharyngeal squamous cell carcinoma. Is there really evidence for a change?
    van Monsjou HS; Schaapveld M; van den Brekel MW; Balm AJ
    Oral Oncol; 2015 Oct; 51(10):901-7. PubMed ID: 26216340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands.
    Wouters MW; Siesling S; Jansen-Landheer ML; Elferink MA; Belderbos J; Coebergh JW; Schramel FM
    Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S83-92. PubMed ID: 20598845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.